Davis HR - Search Results

1

Glucagon receptor antagonism induces increased cholesterol absorption.

Guan HP, Yang X, Lu K, Wang SP, Castro-Perez JM, Previs S, Wright M, Shah V, Herath K, Xie D, Szeto D, Forrest G, Xiao JC, Palyha O, Sun LP, Andryuk PJ, Engel SS, Xiong Y, Lin S, Kelley DE, Erion MD, Davis HR, Wang L. Guan HP, et al. Among authors: davis hr. J Lipid Res. 2015 Nov;56(11):2183-95. doi: 10.1194/jlr.M060897. Epub 2015 Sep 15. J Lipid Res. 2015. PMID: 26373568 Free PMC article.

2

Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9.

Ason B, Tep S, Davis HR Jr, Xu Y, Tetzloff G, Galinski B, Soriano F, Dubinina N, Zhu L, Stefanni A, Wong KK, Tadin-Strapps M, Bartz SR, Hubbard B, Ranalletta M, Sachs AB, Flanagan WM, Strack A, Kuklin NA. Ason B, et al. Among authors: davis hr jr. J Lipid Res. 2011 Apr;52(4):679-87. doi: 10.1194/jlr.M013664. Epub 2011 Jan 24. J Lipid Res. 2011. PMID: 21262787 Free PMC article.

3

Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.

Davis HR, Veltri EP. Davis HR, et al. J Atheroscler Thromb. 2007 Jun;14(3):99-108. doi: 10.5551/jat.14.99. J Atheroscler Thromb. 2007. PMID: 17587760 Free article. Review.

4

Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461.

Salisbury BG, Davis HR, Burrier RE, Burnett DA, Bowkow G, Caplen MA, Clemmons AL, Compton DS, Hoos LM, McGregor DG, et al. Salisbury BG, et al. Among authors: davis hr. Atherosclerosis. 1995 May;115(1):45-63. doi: 10.1016/0021-9150(94)05499-9. Atherosclerosis. 1995. PMID: 7669087

5

2-Azetidinone cholesterol absorption inhibitors: increased potency by substitution of the C-4 phenyl ring.

Vaccaro WD, Sher R, Davis HR Jr. Vaccaro WD, et al. Among authors: davis hr jr. Bioorg Med Chem. 1998 Sep;6(9):1429-37. doi: 10.1016/s0968-0896(98)00073-x. Bioorg Med Chem. 1998. PMID: 9801814

6

Intestinal sterol transporters and cholesterol absorption inhibition.

Davis HR Jr, Tershakovec AM, Tomassini JE, Musliner T. Davis HR Jr, et al. Curr Opin Lipidol. 2011 Dec;22(6):467-78. doi: 10.1097/MOL.0b013e32834c7c28. Curr Opin Lipidol. 2011. PMID: 22101558 Review.

7

Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.

Zheng S, Hoos L, Cook J, Tetzloff G, Davis H Jr, van Heek M, Hwa JJ. Zheng S, et al. Eur J Pharmacol. 2008 Apr 14;584(1):118-24. doi: 10.1016/j.ejphar.2008.01.045. Epub 2008 Feb 12. Eur J Pharmacol. 2008. PMID: 18329014

8

Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats.

van Heek M, Farley C, Compton DS, Hoos LM, Smith-Torhan A, Davis HR. van Heek M, et al. Among authors: davis hr. Br J Pharmacol. 2003 Apr;138(8):1459-64. doi: 10.1038/sj.bjp.0705187. Br J Pharmacol. 2003. PMID: 12721101 Free PMC article.

9

The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.

Davis HR Jr, Pula KK, Alton KB, Burrier RE, Watkins RW. Davis HR Jr, et al. Metabolism. 2001 Oct;50(10):1234-41. doi: 10.1053/meta.2001.26737. Metabolism. 2001. PMID: 11586500

10

Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice.

Vassileva G, Hu W, Hoos L, Tetzloff G, Yang S, Liu L, Kang L, Davis HR, Hedrick JA, Lan H, Kowalski T, Gustafson EL. Vassileva G, et al. Among authors: davis hr. J Endocrinol. 2010 Jun;205(3):225-32. doi: 10.1677/JOE-10-0009. Epub 2010 Mar 30. J Endocrinol. 2010. PMID: 20354075

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page